Adherence therapy for people with schizophrenia in Suanprung Psychiatric Hospital, Thailand
This study is recruiting. It focuses on schizophrenia and currently lists participation information in the United Kingdom and Thailand.
In United Kingdom
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is recruiting. It focuses on schizophrenia and currently lists participation information in the United Kingdom and Thailand.
In United KingdomThis study is recruiting in the United Kingdom and in Thailand. It focuses on schizophrenia.
In United KingdomThis study is recruiting. It focuses on schizophrenia and currently lists participation information in the United Kingdom and Switzerland.
In United KingdomThis study is recruiting. It focuses on anxiety and currently lists participation information in the United Kingdom.
In United KingdomThis study is recruiting. It focuses on depression and currently lists participation information in the United States.
In HoustonThis study is recruiting. It focuses on depression and currently lists participation information in China.
In Hong KongThis study is recruiting. It focuses on depression and currently lists participation information in Zambia.
In LusakaThis study is recruiting. It focuses on depression and currently lists participation information in Finland.
Multiple locations, including HämeenlinnaThis study is recruiting. It focuses on depression and currently lists participation information in the United States.
In Chapel HillThis study is recruiting. It focuses on anxiety and currently lists participation information in Germany.
In HamburgThis study is recruiting. It focuses on PTSD and currently lists participation information in the United States.
In ProvidenceThis study is recruiting. It focuses on ADHD and currently lists participation information in France.
In DuryHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.